Acute Cerebellar Knockdown of Reproduces Salient Features of Myoclonus-dystonia (DYT11) in Mice
Authors
Affiliations
Myoclonus dystonia (DYT11) is a movement disorder caused by loss-of-function mutations in and characterized by involuntary jerking and dystonia that frequently improve after drinking alcohol. Existing transgenic mouse models of DYT11 exhibit only mild motor symptoms, possibly due to rodent-specific developmental compensation mechanisms, which have limited the study of neural mechanisms underlying DYT11. To circumvent potential compensation, we used short hairpin RNA (shRNA) to acutely knock down S in the adult mouse and found that this approach produced dystonia and repetitive, myoclonic-like, jerking movements in mice that improved after administration of ethanol. Acute knockdown of in the cerebellum, but not the basal ganglia, produced motor symptoms, likely due to aberrant cerebellar activity. The acute knockdown model described here reproduces the salient features of DYT11 and provides a platform to study the mechanisms underlying symptoms of the disorder, and to explore potential therapeutic options.
Li Z, Abram L, Peall K Cells. 2024; 13(18.
PMID: 39329704 PMC: 11430605. DOI: 10.3390/cells13181520.
Microstructure of the cerebellum and its afferent pathways underpins dystonia in myoclonus dystonia.
Tarrano C, Zito G, Gallea C, Delorme C, McGovern E, Atkinson-Clement C Eur J Neurol. 2024; 31(12):e16460.
PMID: 39254064 PMC: 11555160. DOI: 10.1111/ene.16460.
Association of abnormal explicit sense of agency with cerebellar impairment in myoclonus-dystonia.
Tarrano C, Gallea C, Delorme C, McGovern E, Atkinson-Clement C, Barnham I Brain Commun. 2024; 6(2):fcae105.
PMID: 38601915 PMC: 11004927. DOI: 10.1093/braincomms/fcae105.
Cerebellar dysfunction in rodent models with dystonia, tremor, and ataxia.
van der Heijden M, Sillitoe R Dystonia. 2023; 2.
PMID: 38105800 PMC: 10722573. DOI: 10.3389/dyst.2023.11515.
Synaptic Dysfunction in Dystonia: Update From Experimental Models.
El Atiallah I, Bonsi P, Tassone A, Martella G, Biella G, Castagno A Curr Neuropharmacol. 2023; 21(11):2310-2322.
PMID: 37464831 PMC: 10556390. DOI: 10.2174/1570159X21666230718100156.